Use: Labeled indications
- Directions Directions: Shake well before using.
Full indications and usage US FDA label
Directions Directions: Shake well before using. The metered pump sprayer provides a precise amount of soothing spray in a fine mist. Clear the nasal passage-way by gently blowing your nose before using. Prior to initial use, remove cap, prime the pump by holding it upright and pumping one or more times until the solution is dispensed.
Insert nozzle into nostril and depress pump completly while breathing in through nose. Clean nozzle after use. Ages 6 years to adult (with adult supervision) - spray 1-2 times in each nostril not more often than every 10 to 12 hours. Do not exceed 2 doses in any 24-hour period.
Dosing: Adult
Dosage and administration (US label) US FDA label
directions Directions: Shake well before using. The metered pump sprayer provides a precise amount of soothing spray in a fine mist. Clear the nasal passage-way by gently blowing your nose before using. Prior to initial use, remove cap, prime the pump by holding it upright and pumping one or more times until the solution is dispensed.
Insert nozzle into nostril and depress pump completely while breathing in through nose. Clean nozzle after use. Ages 6 years to adult (with adult supervision) - spray 1-2 times in each nostril not more often than every 10 to 12 hours. Do not exceed 2 doses in any 24-hour period.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Nasal spray: 0.5 mg/mL, 250 mcg/mL, 500 mcg/mL
- Nasal solution: 250 mcg/mL, 500 mcg/mL
Registered products in the Philippines
13 products registered with the Food and Drug Administration (FDA) Philippines list Oxymetazoline as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products13
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
ClariClearOxymetazoline Hydrochloride | 500 mcg/mL (0.05%) Nasal SprayHDPE/LDPE Bottle, Nasal Spray Plug with LDPE Dip Tube and PP Screw Cap x 15 mL (Box of 1’s) | OTC | Delpharm Montreal Inc.H9R 1B4 | Bayer Philippines, Inc. | DR-XY46699 | Sep 12, 2031 | |
FreenazeOxymetazoline Hydrochloride | 500 mcg/mL (0.05% w/v) Nasal SprayPE Bottle with Spray Pump x 15 mL & 30 mL (Box of 1's) | OTC | Jewim Pharmaceutical (Sandong) Co., Ltd.China | Nextgen Pharmaceuticals Inc. | DRP-17787 | Mar 11, 2031 | |
NasathixOxymetazoline hydrochloride | 250 mcg/mL (0.025% w/v) Nasal SprayLDPE Squeeze Bottle with screw cap x 10 mL (Box of 1's) | OTC | Biodeal Pharmaceuticals Pvt., Ltd.India | Medethix, Inc. | DRP-14884 | Nov 6, 2031 | |
NasathixOxymetazoline Hydrochloride | 500 mcg/mL (0.05% w/v) Nasal SprayWhite LDPE Squeeze Bottle x 10 mL (Box of 1's) | Rx | Biodeal Pharmaceuticals Pvt. Ltd.India | Medethix, Inc.Trader: Aztec Pharma Pvt. Ltd. | DRP-13494 | Feb 28, 2030 | |
NasofixOxymetazoline Hydrochloride | 500 mcg/mL (0.05% w/v) Nasal Spray5 mL and 10 mL (net content) in 10 mL HDPE Bottle with pump (Box of 1’s) | OTC | Jewim Pharmaceutical (Shandong) Co., Ltd.China | Global Pharmatrade | DR-XY42052 | May 31, 2031 | |
NasofreeOxymetazoline Hydrochloride | 0.05 % Nasal Solution (Spray)HDPE White Bottle x 10 mL and 15 mL (Box of 1's) | OTC | Lloyd Laboratories, Inc.Philippines | Trader: Innogen Pharmaceuticals, Inc. | DRP-16480 | Dec 4, 2029 | |
NasofreeOxymetazoline Hydrochloride | 0.05% Nasal Solution (Spray)HDPE White Bottle x 10 mL and 15 mL (Box of 1's) | OTC | Lloyd Laboratories, Inc.Philippines | Trader: Innogen Pharmaceuticals, Inc. | DR-XY37123 | Dec 4, 2029 | |
NoneOxymetazoline Hydrochloride | 250 mcg/mL (0.025% w/v) Nasal Spray10 mL LDPE Squeeze Bottle with Screw Cap (Box of 1's) | OTC | Biodeal Pharmaceuticals Pvt., Ltd.India | Medethix, Inc. | DRP-14040 | Jun 8, 2031 | |
NoneOxymetazoline hydrochloride | 500 mcg/mL (0.05% w/v) Nasal Spray10 mL LDPE Squeeze Bottle with Screw Cap (Box of 1's) | OTC | Biodeal Pharmaceuticals Pvt., Ltd.India | Medethix, Inc. | DRP-14041 | Jun 8, 2031 | |
OXOZOLINOxymetazoline Hydrochloride | 500 mcg/mL (0.05% w/v) Nasal Solution10 mL LDPE Dropper Bottle (Box of 1's) | Rx | ARISTOPHARMA LTD.Bangladesh | SAHAR INTERNATIONAL TRADING INC. | DR-XY43881 | Nov 12, 2029 | |
OxymetOxymetazoline Hydrochloride | 500 mcg/mL (0.05% w/v) Nasal Solution (Drops)10 mL White Opaque HDPE Dropper Bottle (Box of 1’s) | Rx | West-Coast Pharmaceutical Works Ltd.India | Ambica International Corporation | DRP-6624 | Apr 6, 2037 | |
Oxymet PediatricOxymetazoline Hydrochloride | 250 mcg/mL (0.025% w/v) Nasal Solution (Drops)10 mL White Opaque HDPE Dropper Bottle (Box of 1’s) | Rx | West-Coast Pharmaceutical Works Ltd.India | Ambica International Corporation | DRP-6625 | Apr 6, 2038 | |
OxyzolOxymetazoline HCl | 0.5 mg/mL Nasal SprayPE Bottle x 30 mL (Box of 1's) | OTC | Taiguk Pharm. Co,., Ltd.Republic of Korea | Importer: H & B Pharma International Inc. | DRP-8553 | Nov 14, 2029 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Warnings/Precautions
Warnings and precautions (US label) US FDA label
Warnings The use of this container by more than one person may spread infection. Keep out of reach of children. Clean nozzle after each use & replace the cap. Do not exceed recommended dosage. Do not use this product for more than 3 days. If pregnant or breast-feeding, ask a health professional before use. Ask a physician before use if you have - heart disease - high blood pressure - thyroid disease - diabetes - trouble urinating due to enlarged prostate gland - Not for children under age 6 unless directed by a physician.
Formulary and pricing (Philippines)
Government price references
| Preparation | Price (PHP) | Unit | Type |
|---|---|---|---|
| Oxymetazoline 0.05%, 15 mL Bottle | ₱195.00–₱297.00Reference ₱195.00 | per bottle | DPRI procurement range |
Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)
These are government procurement and reimbursement references, not retail prices. Sources:
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf, as of September 17, 2021
Formulary and coverage
| Philippine National Formulary | Listed as Oxymetazoline (as hydrochloride) |
| PNF listing | Nasal Drops Solution: 0.025%, 10 mL bottle Nasal Spray: |
| PNF listing | Nasal Drops Solution: 0.05%, 10 mL and 15 mL bottle |
| PhilHealth GAMOT | No |
Sources:
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf, as of November 2, 2022
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- U.S. Food and Drug Administration. Xlear Nasal Decongestant · Xlear Inc. [US FDA-approved label, version 5, November 9, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1c1db71a-47d0-42ac-8cbe-95e76dca185f
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .